Eltrombopag for the Treatment of Thrombocytopenia of Low and Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Interim Results on Efficacy, Safety and Quality of Life of an International, Multicenter Prospective, Randomized, Trial

被引:1
|
作者
Oliva, Esther Natalie [1 ]
Santini, Valeria [2 ]
Alati, Caterina [1 ]
Poloni, Antonella [3 ]
Molteni, Alfredo [4 ]
Niscola, Pasquale [5 ]
Sanpaolo, Grazia [6 ]
Salvi, Flavia [7 ]
Palumbo, Giuseppe A. [8 ]
Balleari, Enrico [9 ]
Impera, Stefana [10 ]
Cortelezzi, Agostino [11 ]
Liberati, Anna Marina [12 ]
Avanzini, Paolo [13 ]
Di Bartolomeo, Paolo [14 ]
Rose, Christian [15 ]
Beyne-Rauzy, Odile [16 ]
Buccisano, Francesco [17 ]
Bocchia, Monica [18 ]
Morabito, Fortunato [19 ]
Stamatoullas, Aspasia [20 ]
Ronco, Francesca [1 ]
Zini, Gina [21 ]
D'Errigo, Maria Grazia [22 ]
Ranieri, Natale [1 ]
Cufari, Patrizia [1 ]
Santacaterina, Irene [1 ]
Fenaux, Pierre [23 ]
Latagliata, Roberto [24 ]
机构
[1] Azienda Osped Bianchi Melacrino Morelli, Hematol, Reggio Di Calabria, Italy
[2] Univ Florence, AOU Careggi, Florence, Italy
[3] Osped Riuniti Ancona, Haematol Clin, Ancona, Italy
[4] Osped Niguarda Ca Granda, Milan, Italy
[5] S Eugenio Hosp, Dept Hematol, Rome, Italy
[6] Ist Casa Sollievo Sofferenza, Hematol, San Giovanni Rotondo, Italy
[7] SS Antonio & Biagio Hosp, Hematol, Alessandria, Italy
[8] Univ Catania, Div Hematol, Osped Ferrarotto, Catania, Italy
[9] Genova Hosp, Genoa, Italy
[10] ARNAS Garibaldi Nesima, Sect Hematol, Catania, Italy
[11] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Oncohematol Unit, Milan, Italy
[12] Azienda Osped S Maria, SC Oncoematol, Terni, Italy
[13] Santa Maria Nuova Hosp, Hematol, Reggio Emilia, Italy
[14] Osped Civile Santo Spirito, Dipartimento Ematol, Pescara, Italy
[15] Hop St Vincent, Dept Hematol, Lille, France
[16] CHU Purpan, Serv Med Interne, Toulouse, France
[17] Univ Roma Tor Vergata, Hematol, Rome, Italy
[18] Univ Siena, Dept Hematol & Transplants, I-53100 Siena, Italy
[19] AO Annunziata Cosenza, Sect Hematol, Cosenza, Italy
[20] Ctr Henri Becquerel, Clin Hematol, F-76038 Rouen, France
[21] Univ Cattolica Sacro Cuore, Hematol, Ctr Ric ReCAMH, I-00168 Rome, Italy
[22] Azienda Osped Bianchi Melacrino Morelli, Genet Lab, Reggio Di Calabria, Italy
[23] Univ Paris 07, Hop St Louis, Serv Hematol Seniors, Paris, France
[24] Univ Roma La Sapienza, Div Hematol, Dept Cellular Biotechnol & Hematol, I-00185 Rome, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] ELTROMBOPAG FOR THE TREATMENT OF THROMBOCYTOPENIA OF LOW AND INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS OF A PROSPECTIVE, RANDOMIZED, TRIAL
    Oliva, E.
    Santini, V.
    Zini, G.
    Palumbo, G.
    Poloni, A.
    Cortelezzi, A.
    Rodeghiero, F.
    Voso, M.
    Molteni, A.
    Sanpaolo, G.
    Liberati, A.
    Morabito, F.
    Balleari, E.
    Impera, S.
    Salvi, F.
    Spiriti, M.
    Marino, A.
    Roda, F.
    Alati, C.
    Ronco, F.
    Raimondo, F.
    Leoni, P.
    Alimena, G.
    Fioritoni, G.
    Latagliata, R.
    Nobile, F.
    [J]. HAEMATOLOGICA, 2013, 98 : 456 - 456
  • [2] Eltrombopag for the treatment of thrombocytopenia of low and intermediate-1 IPSS risk myelodysplastic syndromes: Results of a prospective, randomized trial
    Oliva, E. N.
    Santini, V.
    Zini, G.
    Palumbo, G. A.
    Poloni, A.
    Cortelezzi, A.
    Rodeghiero, F.
    Voso, M. T.
    Molteni, A.
    Sanpaolo, G.
    Liberati, M.
    Morabito, F.
    Balleari, E.
    Impera, S.
    Salvi, F.
    Spiriti, M. A. Aloe
    Marino, A.
    Roda, F.
    Alati, C.
    Ronco, F.
    Di Raimondo, F.
    Leoni, P.
    Alimena, G.
    Latagliata, R.
    Nobile, F.
    [J]. LEUKEMIA RESEARCH, 2013, 37 : S162 - S162
  • [3] Efficacy and Safety of Eltrombopag for the Treatment of Thrombocytopenia of Low and Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Interim Analysis of a Prospective, Randomized, Single-Blind, Placebo-Controlled Trial (EQoL-MDS)
    Oliva, Esther Natalie
    Santini, Valeria
    Zini, Gina
    Palumbo, Giuseppe A.
    Poloni, Antonella
    Cortelezzi, Agostino
    Voso, Maria Teresa
    Molteni, Alfredo
    Sanpaolo, Grazia
    Marino, Antonio
    Roda, Filippo
    Alati, Caterina
    Ronco, Francesca
    Di Raimondo, Francesco
    Leoni, Pietro
    Alimena, Giuliana
    Finotto, Silvia
    Latagliata, Roberto
    Nobile, Francesco
    [J]. BLOOD, 2012, 120 (21)
  • [4] QUALITY OF LIFE IN PATIENTS WITH LOWER RISK MYELODYSPLASTIC SYNDROMES WITH SEVERE THROMBOCYTOPENIA TREATED WITH ELTROMBOPAG: INTERIM RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED PROSPECTIVE TRIAL
    Oliva, E. N.
    Santini, V.
    Alati, C.
    Sanpaolo, G.
    Poloni, A.
    Molteni, A.
    Ronco, F.
    Palumbo, G.
    Marino, A.
    Impera, S.
    Balleari, E.
    Salutari, P.
    Cufari, P.
    Santacaterina, I.
    Avanzini, P.
    Niscola, P.
    Liberati, A. M.
    Ricco, A.
    Morabito, F.
    Cortelezzi, A.
    Fianchi, L.
    Buccisano, F.
    Fenaux, P.
    Beyne-Rauzy, O.
    Rodeghiero, F.
    Salvi, F.
    Latagliata, R.
    [J]. HAEMATOLOGICA, 2015, 100 : 575 - 576
  • [5] 5-Azacytidine in 82 Low/Intermediate-1 IPSS Risk Myelodysplastic Syndromes: Results from the Italian Patient Named Program
    Musto, Luca Maurillo
    Spagnoli, Alessandra
    Gozzini, Antonella
    Rivellini, Flavia
    Tatarelli, Caterina
    Lunghi, Monia
    Fili, Carla
    Orciuolo, Enrico
    Ciuffreda, Lucia
    Vigna, Ernesto
    Della Cioppa, Paola
    Candoni, Anna
    Ferrero, Dario
    Palmieri, Salvatore
    Palumbo, Giuseppe
    Di Renzo, Nicola
    Oliva, Esther
    Sanpaolo, Grazia
    Pastore, Domenico
    Tonso, Anna
    Santagostino, Alberto
    Rocco, Stefano
    Villani, Oreste
    D'Auria, Fiorella
    D'Arco, Alfonso Maria
    Gaidano, Gianluca
    Galimberti, Sara
    Russo, Domenico
    Venditti, Adriano
    Aloe-Spiriti, Maria Antonietta
    Leone, Giuseppe
    Santini, Valeria
    [J]. BLOOD, 2008, 112 (11) : 926 - 927
  • [6] 5-AZACYTIDINE FOR THE TREATMENT OF LOW/INTERMEDIATE-1 IPSS RISK MYELODYSPLASTIC SYNDROMES: RESULTS IN 63 PATIENTS FROM THE ITALIAN PATIENT NAMED PROGRAM
    Musto, P.
    Maurillo, L.
    Spagnoli, A.
    Gozzini, A.
    Rivellini, F.
    Tatarelli, C.
    Lunghi, M.
    Fili, C.
    Orciuolo, E.
    Ciuffreda, L.
    Vigna, E.
    Della Cioppa, P.
    Ferrero, D.
    Palmieri, S.
    Palumbo, G.
    Di Renzo, N.
    Oliva, E.
    Sanpaolo, G.
    Pastore, D.
    Tonso, A.
    Santagostino, A.
    Villani, O.
    D'Auria, F.
    D'Arco, A.
    Gaidano, G.
    Galimberti, S.
    Russo, D.
    Venditti, A.
    Aloe-Spiriti, M. A.
    Leone, G.
    Santini, V.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 368 - 368
  • [7] Eltrombopag for Low-Risk Myelodysplastic Syndromes With Thrombocytopenia: Interim Results of a Phase II, Randomized, Placebo-Controlled Clinical Trial (EQOL-MDS)
    Oliva, Esther Natalie
    Riva, Marta
    Niscola, Pasquale
    Santini, Valeria
    Breccia, Massimo
    Giai, Valentina
    Poloni, Antonella
    Patriarca, Andrea
    Crisa, Elena
    Capodanno, Isabella
    Salutari, Prassede
    Reda, Gianluigi
    Cascavilla, Nicola
    Ferrero, Dario
    Guarini, Attilio
    Tripepi, Giovanni
    Ianni, Giuseppe
    Russo, Emilio
    Castelli, Andrea
    Fattizzo, Bruno
    Beltrami, Germana
    Bocchia, Monica
    Molteni, Alfredo
    Fenaux, Pierre
    Germing, Ulrich
    Ricco, Alessandra
    Palumbo, Giuseppe A.
    Impera, Stefana
    Di Renzo, Nicola
    Rivellini, Flavia
    Buccisano, Francesco
    Stamatoullas-Bastard, Aspasia
    Liberati, Anna Marina
    Candoni, Anna
    Delfino, Ilaria Maria
    Arcadi, Maria Teresa
    Cufari, Patrizia
    Rizzo, Lorenzo
    Bova, Irene
    D'Errigo, Maria Grazia
    Zini, Gina
    Latagliata, Roberto
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (28) : 4486 - +
  • [8] Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study
    Palandri, Francesca
    Tiribelli, Mario
    Benevolo, Giulia
    Tieghi, Alessia
    Cavazzini, Francesco
    Breccia, Massimo
    Bergamaschi, Micaela
    Sgherza, Nicola
    Polverelli, Nicola
    Crugnola, Monica
    Isidori, Alessandro
    Binotto, Gianni
    Heidel, Florian H.
    Buccisano, Francesco
    Martino, Bruno
    Latagliata, Roberto
    Spinsanti, Marco
    Kallenberg, Lydia
    Palumbo, Giuseppe Alberto
    Abruzzese, Elisabetta
    Scaffidi, Luigi
    Cuneo, Antonio
    Cavo, Michele
    Vianelli, Nicola
    Bonifacio, Massimiliano
    [J]. HEMATOLOGICAL ONCOLOGY, 2018, 36 (01) : 285 - 290
  • [9] Lenalidomide in International Prognostic Scoring System Low and Intermediate-1 risk myelodysplastic syndromes with del(5q): an Italian phase II trial of health-related quality of life, safety and efficacy
    Oliva, Esther N.
    Latagliata, Roberto
    Lagana, Carmelo
    Breccia, Massimo
    Galimberti, Sara
    Morabito, Fortunato
    Poloni, Antonella
    Balleari, Enrico
    Cortelezzi, Agostino
    Palumbo, Giuseppe
    Sanpaolo, Grazia
    Volpe, Antonio
    Specchia, Giorgina
    Finelli, Carlo
    D'Errigo, Maria Grazia
    Roda, Filippo
    Alati, Caterina
    Alimena, Giuliana
    Nobile, Francesco
    Spiriti, Maria A. Aloe
    [J]. LEUKEMIA & LYMPHOMA, 2013, 54 (11) : 2458 - 2465
  • [10] EFFICACY AND SAFETY OF ELTROMBOPAG FOR THE TREATMENT OF THROMBOCYTOPENIA OF LOW AND INT-1 RISK MDS: PRELIMINARY RESULTS OF A PROSPECTIVE, RANDOMIZED, SINGLE-BLIND PLACEBO-CONTROLLED TRIAL
    Oliva, E.
    Latagliata, R.
    Santini, V.
    Palumbo, G.
    Poloni, A.
    Cortelezzi, A.
    Cufari, P.
    Roda, F.
    Marino, A.
    Denisi, G.
    Leoni, P.
    Di Raimondo, F.
    Alimena, G.
    Nobile, F.
    [J]. HAEMATOLOGICA, 2012, 97 : 470 - 470